Douglas W. Pagan
CIK 1628880 · Chief Financial Officer · last filed 2026-04-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
27
Lifetime Open-Market Net
-$698.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KLRA | Chief Financial Officer | — | — | — | $0 | 1 | 2026-04-20 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Chief Financial Officer | 0 | $38.22 | $0 | $0 | 5 | 2021-12-29 |
| Alaunos Therapeutics, Inc. (ZIOP) Delisted | Director | 35,943 | $0.87 | $31.1K | $0 | 3 | 2020-01-03 |
| Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Chief Financial Officer | 70,807 | $2.23 | $157.9K | -$698.0K | 18 | 2019-04-08 |
Recent Filings · Page 2 of 3
27 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-02-04 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Grant (A) | +16,250 | $0 | EDGAR |
| 2019-01-02 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Grant (A) | +40,107 | $0 | EDGAR |
| 2018-12-14 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Sell (S) | −2,918 | -$19.7K | EDGAR |
| 2018-10-16 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Mixed | +3,716 | -$24.9K | EDGAR |
| 2018-10-04 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Mixed | +42,421 | -$74.4K | EDGAR |
| 2018-09-20 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-10 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Sell (S) | −5,237 | -$66.5K | EDGAR |
| 2018-04-05 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Grant (A) | +13,500 | $0 | EDGAR |
| 2018-02-16 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Grant (A) | +29,250 | $0 | EDGAR |
| 2018-02-07 | Paratek Pharmaceuticals, Inc. (PRTK) Delisted | Sell (S) | −16,291 | -$231.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.